Study on the Change of T-cell Subtype with Pegylated Interferon-α and Ribavirin Combined Therapy in Chronic Hepatitis C Patients
碩士 === 弘光科技大學 === 營養醫學研究所 === 104 === Patients with chronic hepatitis C virus (HCV) infection may progress toward cirrhosis, and liver cancer. A combination of pegylated interferon-α and ribavirin is the standard therapy for chronic HCV infection. However,there are currently no immunological predic...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2016
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/unc2zr |